<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d441" origId="Darifenacin"><sentence id="DrugDDI.d441.s0" origId="s0" text="The daily dose of ENABLEX should not exceed 7.5 mg when coadministered with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone) ."><entity id="DrugDDI.d441.s0.e0" origId="s0.p1" charOffset="18-25" type="drug" text="ENABLEX"/><entity id="DrugDDI.d441.s0.e1" origId="s0.p8" charOffset="83-89" type="drug" text="CYP3A4"/><entity id="DrugDDI.d441.s0.e2" origId="s0.p11" charOffset="108-120" type="drug" text="ketoconazole"/><entity id="DrugDDI.d441.s0.e3" origId="s0.p12" charOffset="122-134" type="drug" text="itraconazole"/><entity id="DrugDDI.d441.s0.e4" origId="s0.p13" charOffset="136-145" type="drug" text="ritonavir"/><entity id="DrugDDI.d441.s0.e5" origId="s0.p14" charOffset="147-157" type="drug" text="nelfinavir"/><entity id="DrugDDI.d441.s0.e6" origId="s0.p15" charOffset="159-173" type="drug" text="clarithromycin"/><pair id="DrugDDI.d441.s0.p0" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e1" interaction="true"/><pair id="DrugDDI.d441.s0.p1" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e2" interaction="true"/><pair id="DrugDDI.d441.s0.p2" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e3" interaction="true"/><pair id="DrugDDI.d441.s0.p3" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e4" interaction="true"/><pair id="DrugDDI.d441.s0.p4" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e5" interaction="true"/><pair id="DrugDDI.d441.s0.p5" e1="DrugDDI.d441.s0.e0" e2="DrugDDI.d441.s0.e6" interaction="true"/><pair id="DrugDDI.d441.s0.p6" e1="DrugDDI.d441.s0.e1" e2="DrugDDI.d441.s0.e2" interaction="false"/><pair id="DrugDDI.d441.s0.p7" e1="DrugDDI.d441.s0.e1" e2="DrugDDI.d441.s0.e3" interaction="false"/><pair id="DrugDDI.d441.s0.p8" e1="DrugDDI.d441.s0.e1" e2="DrugDDI.d441.s0.e4" interaction="false"/><pair id="DrugDDI.d441.s0.p9" e1="DrugDDI.d441.s0.e1" e2="DrugDDI.d441.s0.e5" interaction="false"/><pair id="DrugDDI.d441.s0.p10" e1="DrugDDI.d441.s0.e1" e2="DrugDDI.d441.s0.e6" interaction="false"/><pair id="DrugDDI.d441.s0.p11" e1="DrugDDI.d441.s0.e2" e2="DrugDDI.d441.s0.e3" interaction="false"/><pair id="DrugDDI.d441.s0.p12" e1="DrugDDI.d441.s0.e2" e2="DrugDDI.d441.s0.e4" interaction="false"/><pair id="DrugDDI.d441.s0.p13" e1="DrugDDI.d441.s0.e2" e2="DrugDDI.d441.s0.e5" interaction="false"/><pair id="DrugDDI.d441.s0.p14" e1="DrugDDI.d441.s0.e2" e2="DrugDDI.d441.s0.e6" interaction="false"/><pair id="DrugDDI.d441.s0.p15" e1="DrugDDI.d441.s0.e3" e2="DrugDDI.d441.s0.e4" interaction="false"/><pair id="DrugDDI.d441.s0.p16" e1="DrugDDI.d441.s0.e3" e2="DrugDDI.d441.s0.e5" interaction="false"/><pair id="DrugDDI.d441.s0.p17" e1="DrugDDI.d441.s0.e3" e2="DrugDDI.d441.s0.e6" interaction="false"/><pair id="DrugDDI.d441.s0.p18" e1="DrugDDI.d441.s0.e4" e2="DrugDDI.d441.s0.e5" interaction="false"/><pair id="DrugDDI.d441.s0.p19" e1="DrugDDI.d441.s0.e4" e2="DrugDDI.d441.s0.e6" interaction="false"/><pair id="DrugDDI.d441.s0.p20" e1="DrugDDI.d441.s0.e5" e2="DrugDDI.d441.s0.e6" interaction="false"/></sentence><sentence id="DrugDDI.d441.s1" origId="s1" text="Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY)."><entity id="DrugDDI.d441.s1.e0" origId="s1.p24" charOffset="29-36" type="drug" text="ENABLEX"/><entity id="DrugDDI.d441.s1.e1" origId="s1.p28" charOffset="64-75" type="drug" text="medications"/><entity id="DrugDDI.d441.s1.e2" origId="s1.p33" charOffset="114-120" type="drug" text="CYP2D6"/><entity id="DrugDDI.d441.s1.e3" origId="s1.p38" charOffset="173-183" type="drug" text="flecainide"/><entity id="DrugDDI.d441.s1.e4" origId="s1.p39" charOffset="185-197" type="drug" text="thioridazine"/><entity id="DrugDDI.d441.s1.e5" origId="s1.p41" charOffset="202-227" type="drug" text="tricyclic antidepressants"/><pair id="DrugDDI.d441.s1.p0" e1="DrugDDI.d441.s1.e0" e2="DrugDDI.d441.s1.e1" interaction="true"/><pair id="DrugDDI.d441.s1.p1" e1="DrugDDI.d441.s1.e0" e2="DrugDDI.d441.s1.e2" interaction="false"/><pair id="DrugDDI.d441.s1.p2" e1="DrugDDI.d441.s1.e0" e2="DrugDDI.d441.s1.e3" interaction="true"/><pair id="DrugDDI.d441.s1.p3" e1="DrugDDI.d441.s1.e0" e2="DrugDDI.d441.s1.e4" interaction="true"/><pair id="DrugDDI.d441.s1.p4" e1="DrugDDI.d441.s1.e0" e2="DrugDDI.d441.s1.e5" interaction="true"/><pair id="DrugDDI.d441.s1.p5" e1="DrugDDI.d441.s1.e1" e2="DrugDDI.d441.s1.e2" interaction="false"/><pair id="DrugDDI.d441.s1.p6" e1="DrugDDI.d441.s1.e1" e2="DrugDDI.d441.s1.e3" interaction="false"/><pair id="DrugDDI.d441.s1.p7" e1="DrugDDI.d441.s1.e1" e2="DrugDDI.d441.s1.e4" interaction="false"/><pair id="DrugDDI.d441.s1.p8" e1="DrugDDI.d441.s1.e1" e2="DrugDDI.d441.s1.e5" interaction="false"/><pair id="DrugDDI.d441.s1.p9" e1="DrugDDI.d441.s1.e2" e2="DrugDDI.d441.s1.e3" interaction="false"/><pair id="DrugDDI.d441.s1.p10" e1="DrugDDI.d441.s1.e2" e2="DrugDDI.d441.s1.e4" interaction="false"/><pair id="DrugDDI.d441.s1.p11" e1="DrugDDI.d441.s1.e2" e2="DrugDDI.d441.s1.e5" interaction="false"/><pair id="DrugDDI.d441.s1.p12" e1="DrugDDI.d441.s1.e3" e2="DrugDDI.d441.s1.e4" interaction="false"/><pair id="DrugDDI.d441.s1.p13" e1="DrugDDI.d441.s1.e3" e2="DrugDDI.d441.s1.e5" interaction="false"/><pair id="DrugDDI.d441.s1.p14" e1="DrugDDI.d441.s1.e4" e2="DrugDDI.d441.s1.e5" interaction="false"/></sentence><sentence id="DrugDDI.d441.s2" origId="s2" text="The concomitant use of ENABLEX with other anticholinergic agents may increase the frequency and/or severity of dry mouth, constipation, blurred vision and other anticholinergic pharmacological effects."><entity id="DrugDDI.d441.s2.e0" origId="s2.p47" charOffset="23-30" type="drug" text="ENABLEX"/><entity id="DrugDDI.d441.s2.e1" origId="s2.p48" charOffset="42-64" type="drug" text="anticholinergic agents"/><entity id="DrugDDI.d441.s2.e2" origId="s2.p58" charOffset="161-176" type="drug" text="anticholinergic"/><pair id="DrugDDI.d441.s2.p0" e1="DrugDDI.d441.s2.e0" e2="DrugDDI.d441.s2.e1" interaction="true"/><pair id="DrugDDI.d441.s2.p1" e1="DrugDDI.d441.s2.e0" e2="DrugDDI.d441.s2.e2" interaction="false"/><pair id="DrugDDI.d441.s2.p2" e1="DrugDDI.d441.s2.e1" e2="DrugDDI.d441.s2.e2" interaction="false"/></sentence><sentence id="DrugDDI.d441.s3" origId="s3" text="Anticholinergic agents may potentially alter the absorption of some concomitantly administered drugs due to effects on gastrointestinal motility."><entity id="DrugDDI.d441.s3.e0" origId="s3.p59" charOffset="0-22" type="drug" text="Anticholinergic agents"/><entity id="DrugDDI.d441.s3.e1" origId="s3.p64" charOffset="95-100" type="drug" text="drugs"/><pair id="DrugDDI.d441.s3.p0" e1="DrugDDI.d441.s3.e0" e2="DrugDDI.d441.s3.e1" interaction="true"/></sentence><sentence id="DrugDDI.d441.s4" origId="s4" text="Drug Laboratory Test Interactions Interactions between darifenacin and laboratory tests have not been studied."><entity id="DrugDDI.d441.s4.e0" origId="s4.p68" charOffset="55-66" type="drug" text="darifenacin"/></sentence></document>